Boston Scientific (BSX) net assets (shareholders' equity)

Net assets · fiscal 2025
$24.23B

Boston Scientific (BSX) had net assets of $24.23B at the end of fiscal 2025 (December 31, 2025). That is 11.3% higher than the $21.77B of fiscal 2024. Figures as of 18 Nov 2026, 19:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$24.23B
Change on fiscal 2024
+11.3%
Growth, 5 years
+9.6% a year
Growth, 10 years
+14.4% a year
Highest on record
$24.23Bfiscal 2025
Lowest on record
$6.32Bfiscal 2015
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Boston Scientific net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 9.6% a year; over ten years the rate was 14.4% a year. Across the 18 fiscal years on record (2008–2025), the highest was $24.23B in fiscal 2025 and the lowest $6.32B in fiscal 2015.

History · 18 fiscal years

Net assets by fiscal year

Boston Scientific net assets (shareholders' equity), year by year

Boston Scientific (BSX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$24.23B 11.3% up
2024$21.77B 12.9% up
2023$19.28B 9.7% up
2022$17.57B 5.7% up
2021$16.62B 8.5% up
2020$15.33B 10.4% up
2019$13.88B 59.0% up
2018$8.73B 24.4% up
2017$7.01B 4.1% up
2016$6.73B 6.5% up
2015$6.32B 2.1% down
2014$6.46B 1.3% down
2013$6.54B 4.8% down
2012$6.87B 39.5% down
2011$11.35B 0.5% up
2010$11.30B 8.2% down
2009$12.30B 6.6% down
2008$13.17B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Boston Scientific and comparable companies
CompanyNet assetsFiscal year
Takeda Pharmaceutical TAK¥7.43T2026
Cencora COR$1.51B2025
Boston Scientific BSX$24.23B2025
Cardinal Health CAH-$2.88B2026
argenx ARGX$7.32B2025
Edwards Lifesciences EW$10.34B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BSX

Boston Scientific, figure by figure

Boston Scientific (BSX) overview: price, valuation and scorecardAll health care companies by market value

Boston Scientific net assets (shareholders' equity): questions and answers

What are Boston Scientific's net assets?

Boston Scientific (BSX) had net assets of $24.23B at the end of fiscal 2025 (December 31, 2025). That is 11.3% higher than the $21.77B of fiscal 2024.

What is the growth rate of Boston Scientific's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 9.6% a year; over ten years the rate was 14.4% a year.

What are the highest and lowest net assets figures on record for Boston Scientific?

Across the 18 fiscal years on record (2008–2025), the highest was $24.23B in fiscal 2025 and the lowest $6.32B in fiscal 2015.

How is Boston Scientific's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Boston Scientific it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Boston Scientific (BSX) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/BSX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.